Scopolamine Hydrobromide Injection 0.4 mg (Scopolamine Hydrobromide LIQUID) 0.4 MG

Scopolamine Hydrobromide Injection 0.4 mg is a medication used for motion sickness and postoperative nausea. This intramuscular liquid injection is manufactured by Omega Laboratories Limited in Canada.

Strength

0.4 MG

Pack Size

10X1ML

Manufacturer / TM Owner

OMEGA LABORATORIES LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Scopolamine Hydrobromide Injection is commonly used to prevent and treat motion sickness. It may also be used to manage postoperative nausea and vomiting. This medication works by affecting the part of the brain that controls nausea and vomiting. Always consult a healthcare provider to determine if this medication is suitable for your needs.

Side Effects

Common effects of Scopolamine Hydrobromide Injection may include dry mouth, blurred vision, and drowsiness. Some users might experience dizziness or confusion. These effects vary among individuals and are not exhaustive. Always monitor for any adverse reactions and seek medical advice if necessary.

Precautions & Warnings

Handle Scopolamine Hydrobromide Injection with care, ensuring it is stored properly and administered correctly. This medication should be used under medical supervision. Avoid driving or operating heavy machinery until you know how it affects you. Keep out of reach of children and pets.

Avoid Interactions

Scopolamine Hydrobromide Injection may interact with other medications, including anticholinergics and antidepressants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other sedatives may enhance the drowsiness caused by this medication.

Frequently Asked Questions

Scopolamine Hydrobromide Injection is primarily used to prevent and treat motion sickness and postoperative nausea and vomiting.

This medication is administered intramuscularly, typically by a healthcare professional.

Common side effects may include dry mouth, blurred vision, drowsiness, dizziness, and confusion.

It may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

This medication should be used under medical supervision, as it may not be suitable for everyone, especially those with certain medical conditions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.